arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Design Therapeutics, Inc.

DSGN

$9.64 ▼ -0.98 (-9.23%) at close

27 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Design Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $602.6M

Dividend Yield —

Revenue Growth —

Op. Margin None

ROIC -8.7% ↘

FCF / Share $-0.25 ↗

Trailing P/E —

Price / Book 3.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-20.16M

↓ -5.7% —

FCF / Share Free cash flow per share

$-0.25

↑ +7.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	5.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	6.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-12.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-30.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-61.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-55.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	17.9% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	41.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	42.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	—	-55.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-52.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-92.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-5.7% Weak ↑ Weak Improving Year-over-year change in net income	0.4% Caution ↑ Caution Improving Year-over-year change in net income	-17.2% Weak ↑ Weak Improving Year-over-year change in net income	-30.4% Weak ↑ Weak Improving Year-over-year change in net income	-61.8% Weak ↓ Weak Declining Year-over-year change in net income	-59.5% Weak ↓ Weak Declining Year-over-year change in net income	-15.3% Weak ↓ Weak Declining Year-over-year change in net income	17.4% Good ↓ Good Declining Year-over-year change in net income	40.8% Excellent ↑ Excellent Improving Year-over-year change in net income	42.4% Excellent ↑ Excellent Improving Year-over-year change in net income	31.7% Excellent ↑ Excellent Improving Year-over-year change in net income	10.8% Fair ↑ Fair Improving Year-over-year change in net income	-32.9% Weak ↑ Weak Improving Year-over-year change in net income	-45.5% Weak ↑ Weak Improving Year-over-year change in net income	-56.7% Weak ↑ Weak Improving Year-over-year change in net income	-56.4% Weak ↑ Weak Improving Year-over-year change in net income	-96.4% Weak ↑ Weak Improving Year-over-year change in net income	-140.6% Weak ↑ Weak Improving Year-over-year change in net income	-187.0% Weak ↑ Weak Improving Year-over-year change in net income	-387.8% Weak ↑ Weak Improving Year-over-year change in net income	-429.5% Weak Weak Year-over-year change in net income	-731.7% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	10.0% Fair Fair Year-over-year change in free cash flow	—	—	—	-32.8% Weak Weak Year-over-year change in free cash flow	—	—	—	28.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-438.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3025%)	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-466.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3991%)	—
FCF / Net Income (x)	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	4.01x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	27.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	23.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	20.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	11.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-2.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-1.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-8.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-7.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-8.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-5.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-4.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-4.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-4.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-6.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-6.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-5.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-4.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	-3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-2.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	-2.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	-1.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	-1.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-109%)	34.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+127%)	29.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+96%)	26.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+74%)	16.1% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+7%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-643.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-34.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-12.91M	$-12.77M	$-16.86M	$-15.09M	$-19.70M	$-13.67M	$-22.56M	$-30.33M	$-45.70M	$-29.40M	$-21.20M	$-27.94M	$-27.20M	$-28.81M	$-26.50M	$-42.52M	$-119.65M	$-287.31M	$-298.57M	—	—	$-400.69M	$-2.38M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.32	$-0.29	$-0.27	$-0.30	$-0.34	$-0.31	$-0.24	$-0.23	$-0.21	$-0.20	$-0.21	$-0.28	$-0.36	$-0.35	$-0.31	$-0.32	$-0.27	—	$-0.20	$-0.21	$-0.14	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.25	$-0.27	—	$-0.20	—	$-0.30	—	—	—	$-0.22	—	—	—	$-0.31	—	—	—	—	—	$-0.17	$-0.15	—	—	—	—	—	—
Book Value per Share (USD)	$3.23	$3.49	$3.52	$3.51	$3.74	$4.01	$4.27	$4.46	$4.61	$4.77	$4.92	$5.09	$5.30	$5.59	$5.86	$6.11	$6.41	$6.66	$6.89	$7.10	$7.29	$7.41	$-0.71	—	—	—	—
Tangible Book Value per Share (USD)	$3.23	$3.49	$3.52	$3.51	$3.74	$4.01	$4.27	$4.46	$4.61	$4.77	$4.92	$5.09	$5.30	$5.59	$5.86	$6.11	$6.41	$6.66	$6.89	$7.10	$7.29	$7.41	$-0.71	—	—	—	—
Basic Weighted Avg Shares (shares)	62.51M	61.43M	—	56.95M	56.86M	56.76M	—	56.62M	56.56M	56.49M	—	55.99M	55.95M	55.91M	—	55.78M	55.67M	—	—	55.16M	55.08M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$200.77M	$216.86M	$210.73M	$197.86M	$211.05M	$225.41M	$239.58M	$249.81M	$258.45M	$266.79M	$274.96M	$282.15M	$293.91M	$309.89M	$324.34M	$338.08M	$354.33M	$368.39M	$380.15M	—	—	$408.05M	$33.90M	—	—	—	—
Total Equity (USD)	$201.86M	$218.05M	$212.50M	$199.72M	$213.04M	$227.92M	$242.10M	$252.45M	$261.24M	$269.56M	$277.69M	$284.96M	$296.80M	$312.82M	$327.31M	$340.94M	$357.16M	$370.31M	$382.13M	$391.56M	$401.60M	$408.01M	$-11.31M	$-7.89M	$-5.54M	$-4.12M	$-3.64M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$33.00K	$20.00K	$31.00K	$142.00K	—
Depreciation Expense (USD)	$151.00K	$157.00K	$156.00K	$155.00K	—	$159.00K	$149.00K	—	—	$143.00K	$138.00K	—	—	$129.00K	$124.00K	—	—	$82.00K	$82.00K	$31.00K	$12.00K	$4.00K	$4.00K	—	—	—	—
Net Income, GAAP (USD)	$-20.16M	$-17.64M	$-16.00M	$-17.00M	$-19.08M	$-17.71M	$-13.65M	$-13.04M	$-11.79M	$-11.11M	$-11.84M	$-15.79M	$-19.94M	$-19.29M	$-17.34M	$-17.70M	$-15.00M	$-13.27M	$-11.06M	$-11.32M	$-7.64M	$-5.51M	$-3.85M	$-2.32M	$-1.44M	$-663.00K	—
Operating Cash Flow (USD)	$-15.52M	$-16.43M	$-11.97M	$-11.16M	—	$-16.79M	$-9.86M	—	—	$-12.44M	$-12.80M	—	—	$-17.42M	$-15.09M	—	—	$-11.83M	$-9.23M	$-8.16M	$-8.29M	$-3.70M	$-2.84M	$-1.86M	$-1.31M	$-2.66M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 27 quarters

Design Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DSGN with peers